Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-11-20
2007-11-20
Shameem, Golam M. M. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S141000, C544S144000, C544S358000, C544S373000, C548S966000, C514S231200, C514S233500, C514S414000
Reexamination Certificate
active
11462062
ABSTRACT:
The invention relates to compounds of formula:as well as the possible salts thereof with mineral or organic acids, and the solvates and/or hydrates thereof, which have affinity for and selectivity towards the V1breceptors or towards both the V1band V1areceptors of arginine-vasopressin.The invention also relates to the process for preparing them, to the intermediate compounds of formula (II) that are useful for preparing them, to pharmaceutical compositions containing them and to their use for the preparation of medicinal products.
REFERENCES:
patent: 5338755 (1994-08-01), Wagnon et al.
patent: 5594023 (1997-01-01), Wagnon et al.
patent: 5773612 (1998-06-01), Wagnon et al.
patent: 6730695 (2004-05-01), Roux et al.
patent: 6864277 (2005-03-01), Roux et al.
patent: 7129240 (2006-10-01), Roux et al.
patent: WO 95/18105 (1995-07-01), None
Gal Claudine Serradeil-Le
Roux Richard
Tonnerre Bernard
Wagnon Jean
LandOfFree
1,3-dihydro-2 H -indol-2-one derivatives, process for... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 1,3-dihydro-2 H -indol-2-one derivatives, process for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1,3-dihydro-2 H -indol-2-one derivatives, process for... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3854691